Science Explorer Interactive view Map
Company · Munich · Germany

Gilead Sciences (Germany)

gilead.com/about/worldwide-operations/europe/germanyROR OpenAlex
Research works
26
▲ 48% vs 2013–17
Citations
301
11.4 per fractional work
Top-10% rate
1.6%
record average 16.5%
Open access
22%
world 28%

Not ranked overall: Gilead Sciences (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.29× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 5.93× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 0.39× its world share, 0 worksPharmacology, Toxico…Medicine: 4.00× its world share, 4 worksMedicineDecision Sciences: 3.00× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.06× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.80× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.9×. Every wedge is a field page.

Which keywords describe research at Gilead Sciences (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Immune Response, Antiviral Therapy, Liver Disease, Epidemiology, Treatment, Hepatitis C Virus, Ribavirin and Hepatocellular Carcinoma.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 23 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 23 words, with their numbers
  1. Immune Response7▲ 45×6 topics
  2. Antiviral Therapy7▲ 165×3 topics
  3. Liver Disease7▲ 181×2 topics
  4. Epidemiology6▲ 5.8×12 topics
  5. Treatment5▲ 13×6 topics
  6. Hepatitis C Virus4▲ 288×1 topic
  7. Ribavirin4▲ 288×1 topic
  8. Hepatocellular Carcinoma3▲ 59×3 topics
  9. Global Burden3▲ 20×2 topics
  10. Antiretroviral Therapy3▲ 43×5 topics
  11. Chronic Hepatitis B3▲ 189×1 topic
  12. Hepatitis B Virus3▲ 189×1 topic
  13. Immunotherapy2▲ 10×7 topics
  14. Hepatotoxicity1▲ 73×2 topics
  15. HIV Infection1▲ 40×2 topics
  16. Inflammation1▲ 2.1×12 topics
  17. Autoantibodies1▲ 20×6 topics
  18. Drug Resistance1▲ 14×2 topics
  19. HIV1▲ 39×4 topics
  20. Rituximab1▲ 28×3 topics
  21. Integrase Inhibitors1▲ 92×1 topic
  22. Nucleoside Analogues1▲ 92×1 topic
  23. Vaccine1▲ 9.6×3 topics

Which research topics does Gilead Sciences (Germany) publish most on?

By volume in 2022–2025: Biotechnology and Related Fields, Crime, Illicit Activities, and Governance, CAR-T cell therapy research and Lymphoma Diagnosis and Treatment.

Biotechnology and Related Fields: 0 fractional worksCrime, Illicit Activities, and Governance: 0 fractional worksCAR-T cell therapy resea…0CAR-T cell therapy research: 0 fractional worksLymphoma Diagnosis and T…0Lymphoma Diagnosis and Treatment: 0 fractional worksHIV/AIDS drug development and treatment: 0 fractional worksHepatitis C virus research: 0 fractional worksHIV/AIDS Research and In…0HIV/AIDS Research and Interventions: 0 fractional worksChronic Lymphocytic Leukemia Research: 0 fractional worksHIV Research and Treatment: 0 fractional worksFrailty in Older Adults0Frailty in Older Adults: 0 fractional works
Public Health, Environmental and Occupational HealthSociology and Political ScienceOncologyPathology and Forensic Medicine5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Biotechnology and Related Fields Public Health, Environmental and Occupational Health 0 works
  2. 2 Crime, Illicit Activities, and Governance Sociology and Political Science 0 works
  3. 3 CAR-T cell therapy research Oncology 0 works
  4. 4 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  5. 5 HIV/AIDS drug development and treatment Infectious Diseases 0 works
  6. 6 Hepatitis C virus research Hepatology 0 works
  7. 7 HIV/AIDS Research and Interventions Infectious Diseases 0 works
  8. 8 Chronic Lymphocytic Leukemia Research Genetics 0 works
  9. 9 HIV Research and Treatment Virology 0 works
  10. 10 Frailty in Older Adults Geriatrics and Gerontology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available22.0%not open78.0%

World: 28% of research is openly available.

with international co-authors48.4%domestic only51.6%

World: 19% is written across borders.

How has Gilead Sciences (Germany)'s research output changed?

Output in 2018–2022 was 48% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Munich

All research institutions in Munich

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.